Amber Jimenez

Amber Jimenez

Auto-generated profile, based on publicly available information

Amber Jimenez

Department of Dermatology, University of Utah , Salt Lake City, UT

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in JAAD Case Reports
Verified
Journal Article
Open access
AJAmber Jimenez
Amber Jimenez
CHChristopher Hull
Christopher Hull
JZJohn Zone
John Zone

1 April 2021 in JAAD Case Reports
Verified
Journal Article
Open access
AJAmber Jimenez
Amber Jimenez
CHChristopher Hull
Christopher Hull
JZJohn Zone
John Zone

29 October 2021 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
AJAmber Jimenez
Amber Jimenez
KBKimberly Blain
Kimberly Blain
MKMazdak Khalighi
Mazdak Khalighi
JCJennie T. Clarke
Jennie T. Clarke
JSJeremy Snook
Jeremy Snook
SCSarah D. Cipriano
Sarah D. Cipriano

4 December 2025 in British Journal of Dermatology
Verified
Journal Article
Open access
RSRachel M Seifert
Rachel M Seifert
CNChristiaan H Noot
Christiaan H Noot
VSVikram N Sahni
Vikram N Sahni
AJAmber Jimenez
Amber Jimenez
LGLaurel Gray
Laurel Gray
CHChristopher B Hansen
Christopher B Hansen
Effective tools for improving sclerotic hand changes in patients with systemic sclerosis are lacking; thus, we conducted a single-blind prospective randomized clinical trial investigating the impact of UVA1 phototherapy on scleroderma of the hands. Seven patients were unilaterally treated, and we found no evidence of significant change in Hand Mobility in Scleroderma (HAMIS) scores after 30 treatments. However, patients did report significant health-related outcome changes in the emotional, symptomatic and functional domains of Skindex-16 [β = –34.1 (95% CI –47.0 to –21.3), –26.3 (–38.1 to –14.4) and –13.1 (–20.9 to –5.41), respectively].